CTLA-4 is required for the induction of high dose oral tolerance

Int Immunol. 1998 Apr;10(4):491-8. doi: 10.1093/intimm/10.4.491.

Abstract

Mucosal and systemic administrations of high dose antigens induce long-lasting peripheral T cell tolerance. We and others have shown that high dose peripheral T cell tolerance is mediated by anergy or deletion and is preceded by T cell activation. Co-stimulatory molecules B7-1 (CD80)/B7-2 (CD86) and their counter-receptors CD28/CTLA-4 play pivotal roles in T cell activation and immune regulation. In the present study, we examined the roles of the B7 co-stimulation pathway in the generation of high dose peripheral T cell tolerance. We found that blocking B7:CD28/CTLA-4 interaction at the time of tolerance induction partially prevented T cell tolerance, whereas selective blockade of B7:CTLA-4 interaction completely abrogated peripheral T cell tolerance induced by either oral or i.p. antigens. These results suggest that CTLA-4-mediated feedback regulation plays a crucial role in the induction of high dose peripheral T cell tolerance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abatacept
  • Administration, Oral
  • Animals
  • Antigens / administration & dosage
  • Antigens / immunology
  • Antigens, CD
  • Antigens, Differentiation / immunology*
  • B7-1 Antigen / immunology
  • CD28 Antigens / immunology
  • CTLA-4 Antigen
  • Dose-Response Relationship, Drug
  • Female
  • Immune Tolerance / immunology*
  • Immunoconjugates*
  • Lymphocyte Activation / immunology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Signal Transduction / physiology
  • T-Lymphocytes / immunology

Substances

  • Antigens
  • Antigens, CD
  • Antigens, Differentiation
  • B7-1 Antigen
  • CD28 Antigens
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Ctla4 protein, mouse
  • Immunoconjugates
  • Abatacept